Reseach in Chronic Lymphocytic Leukaemia at the Clínic

Reading time: 1 min

Chronic lymphocytic leukaemia research is mostly carried out at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and the haematology area. Specifically, the following groups are involved:

  • Biomedical epigenomics
  • Molecular pathology in lymphoid neoplasms
  • Experimental therapies in lymphoid neoplasms

The Clínic leads numerous international translational research projects (e.g. the genome sequencing project in LLC [ICGC-CLL], the Lymphoma/Molecular Leukaemia Profiling Project [LLMPP]) and more than 20 clinical trials with new drugs. The use of CAR T-cell therapy (T-cells with chimeric antigenic receptors) in the treatment of lymphomas and lymphoid leukaemias is also important, with it being one of the centres accredited nationwide for the use of such treatment, both at the academic and commercial level.

What is Cancer?

General information about Cancer

Read more
The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.


Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.